Judita Anthi

Judita Anthi

Auto-generated profile, based on publicly available information

Judita Anthi

FZU - Institute of Physics of the Czech Academy of Sciences

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
JAJudita Anthi
Judita Anthi
VKViliam Kolivoška
Viliam Kolivoška
BHBarbora Holubova
Barbora Holubova
Hana Vaisocherova-LisalovaHana Vaisocherova-Lisalova
Hana Vaisocherova-Lisalova
Polymer brush tethered to the electrode/electrolyte interface being probed by electrochemical impedance spectroscopy.


26 March 2025 in JACS Au
Verified
Journal Article
Open access
PEPetra Elblová
Petra Elblová
JAJudita Anthi
Judita Anthi
MLMinghui Liu
Minghui Liu
MLMariia Lunova
Mariia Lunova
MJMilan Jirsa
Milan Jirsa
Oleg LunovOleg Lunov
Oleg Lunov
DNA nanotechnology has revolutionized materials science and biomedicine by enabling precise manipulation of matter at the nanoscale. DNA nanostructures (DNs) in particular represent a promising frontier for targeted therapeutics. Engineered DNs offer unprecedented molecular programmability, biocompatibility, and structural versatility, making them ideal candidates for advanced drug delivery, organelle regulation, and cellular function modulation. This Perspective explores the emerging role of DNs in modulating cellular behavior through organelle-targeted interventions. We highlight current advances in nuclear, mitochondrial, and lysosomal targeting, showcasing applications ranging from gene delivery to cancer therapeutics. For instance, DNs have enabled precision mitochondrial disruption in cancer cells, lysosomal pH modulation to enhance gene silencing, and nuclear delivery of gene-editing templates. While DNs hold immense promise for advancing nanomedicine, outstanding challenges include optimizing biological interactions and addressing safety concerns. This Perspective highlights the current potential of DNs for rational control of targeted organelles, which could lead to novel therapeutic strategies and advancement of precision nanomedicines in the future.

31 July 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MFMichala Forinová
Michala Forinová
APAlina Pilipenco
Alina Pilipenco
IVIvana Víšová
Ivana Víšová
NLN. Scott Lynn
N. Scott Lynn
JDJakub Dostalek
Jakub Dostalek
Hana Vaisocherova-LisalovaHana Vaisocherova-Lisalova
Hana Vaisocherova-Lisalova